These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7153344)

  • 1. Solid-phase radioimmunoassay for detection of plague antigen in animal tissue.
    Soergel ME; Schaffer FL; Blank HF
    J Clin Microbiol; 1982 Nov; 16(5):953-6. PubMed ID: 7153344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Detection of a specific plague microbe antigen (fraction I) by the method of radioimmunological analysis].
    Lesovoĭ VS; Berezina ON; Manolov AD; Luk'ianenko IuI
    Lab Delo; 1984; (3):185-6. PubMed ID: 6200692
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative tests for detection of plague antigen and antibody in experimentally infected wild rodents.
    Shepherd AJ; Hummitzsch DE; Leman PA; Swanepoel R; Searle LA
    J Clin Microbiol; 1986 Dec; 24(6):1075-8. PubMed ID: 3097065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Failure of intragastrically administered Yersinia pestis capsular antigen to protect mice against challenge with virulent plague: suppression of fraction 1-specific antibody response.
    Thomas RE; Simpson WJ; Perry LL; Schwan TG
    Am J Trop Med Hyg; 1992 Jul; 47(1):92-7. PubMed ID: 1386197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection and isolation of Yersinia pestis without fraction 1 antigen by monoclonal antibody in foods and water.
    Zhao T; Zhao P; Doyle MP
    J Food Prot; 2012 Sep; 75(9):1555-61. PubMed ID: 22947461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developing subunit immunogens using B and T cell epitopes and their constructs derived from the F1 antigen of Yersinia pestis using novel delivery vehicles.
    Sabhnani L; Manocha M; Sridevi K; Shashikiran D; Rayanade R; Rao DN
    FEMS Immunol Med Microbiol; 2003 Oct; 38(3):215-29. PubMed ID: 14522457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A rapid diagnostic test for plague detects Yersinia pestis F1 antigen in ancient human remains].
    Bianucci R; Rahalison L; Ferroglio E; Massa ER; Signoli M
    C R Biol; 2007 Oct; 330(10):747-54. PubMed ID: 17905394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stable reagent for the detection of antibody to the specific fraction I antigen of Yersinia pestis.
    Rust JH; Berman S; Habig WH; Marshall JD; Cavanaugh DC
    Appl Microbiol; 1972 Apr; 23(4):721-4. PubMed ID: 5062977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cross immunity to plague and tularemia].
    Vasenin AS; Veĭnblat VI; Samoĭlova LV
    Zh Mikrobiol Epidemiol Immunobiol; 1980; (2):49-52. PubMed ID: 7395403
    [No Abstract]   [Full Text] [Related]  

  • 10. Recombinant capsular antigen (fraction 1) from Yersinia pestis induces a protective antibody response in BALB/c mice.
    Simpson WJ; Thomas RE; Schwan TG
    Am J Trop Med Hyg; 1990 Oct; 43(4):389-96. PubMed ID: 2240367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic protection of mice against plague with monoclonal antibodies specific for the F1 and V antigens of Yersinia pestis.
    Hill J; Copse C; Leary S; Stagg AJ; Williamson ED; Titball RW
    Infect Immun; 2003 Apr; 71(4):2234-8. PubMed ID: 12654847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Precipitin reactions with soluble antigens from suspensions of Pasteurella pestis or from tissues of animals dead of plague.
    LARSON CL; PHILIP CB; WICHT WC; HUGHES LE
    J Immunol; 1951 Oct; 67(4):289-98. PubMed ID: 14888892
    [No Abstract]   [Full Text] [Related]  

  • 13. [Some features of action of "murine" toxin and Yersinia pestis antigen fraction I in cells sensitive to animal plague].
    Aseeva LE; Mishan'kin MB; Goncharov EK; Shevchenko LA
    Biull Eksp Biol Med; 1995 Feb; 119(2):193-5. PubMed ID: 7670051
    [No Abstract]   [Full Text] [Related]  

  • 14. Standardization of the dot enzyme-linked immunosorbent assay (dot-ELISA) for experimental plague.
    Montenegro SM; De Almeida AM; Carvalho Júnior LB
    Mem Inst Oswaldo Cruz; 1993; 88(1):119-23. PubMed ID: 8246746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutralization of Yersinia pestis-mediated macrophage cytotoxicity by anti-LcrV antibodies and its correlation with protective immunity in a mouse model of bubonic plague.
    Zauberman A; Cohen S; Levy Y; Halperin G; Lazar S; Velan B; Shafferman A; Flashner Y; Mamroud E
    Vaccine; 2008 Mar; 26(13):1616-25. PubMed ID: 18304706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A DNA vaccine producing LcrV antigen in oligomers is effective in protecting mice from lethal mucosal challenge of plague.
    Wang S; Heilman D; Liu F; Giehl T; Joshi S; Huang X; Chou TH; Goguen J; Lu S
    Vaccine; 2004 Sep; 22(25-26):3348-57. PubMed ID: 15308359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation of monoclonal antibody to V antigen from Yersinia pestis.
    Sato K; Nakajima R; Hara F; Une T; Osada Y
    Contrib Microbiol Immunol; 1991; 12():225-9. PubMed ID: 1935094
    [No Abstract]   [Full Text] [Related]  

  • 18. Recombinant V antigen protects mice against pneumonic and bubonic plague caused by F1-capsule-positive and -negative strains of Yersinia pestis.
    Anderson GW; Leary SE; Williamson ED; Titball RW; Welkos SL; Worsham PL; Friedlander AM
    Infect Immun; 1996 Nov; 64(11):4580-5. PubMed ID: 8890210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a multiple-antigen protein fusion vaccine candidate that confers protection against Bacillus anthracis and Yersinia pestis.
    Gallagher TB; Mellado-Sanchez G; Jorgensen AL; Moore S; Nataro JP; Pasetti MF; Baillie LW
    PLoS Negl Trop Dis; 2019 Aug; 13(8):e0007644. PubMed ID: 31430284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short- and long-term humoral immune response against Yersinia pestis in plague patients, Madagascar.
    Andrianaivoarimanana V; Iharisoa AL; Rahalison L; Ralimanantsoa ML; Ratsitorahina M; Rakotonanahary RJL; Carniel E; Demeure C; Rajerison M
    BMC Infect Dis; 2020 Nov; 20(1):822. PubMed ID: 33172393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.